TD Private Client Wealth LLC raised its stake in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 24.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,697 shares of the company’s stock after purchasing an additional 331 shares during the quarter. TD Private Client Wealth LLC’s holdings in Bath & Body Works were worth $54,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of BBWI. True Wealth Design LLC grew its holdings in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Bath & Body Works by 300.0% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares in the last quarter. Meeder Asset Management Inc. grew its holdings in shares of Bath & Body Works by 480.3% in the third quarter. Meeder Asset Management Inc. now owns 1,735 shares of the company’s stock valued at $55,000 after acquiring an additional 1,436 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Bath & Body Works by 34.4% in the third quarter. GAMMA Investing LLC now owns 2,481 shares of the company’s stock valued at $79,000 after acquiring an additional 635 shares in the last quarter. Finally, Blue Trust Inc. grew its holdings in shares of Bath & Body Works by 23.4% in the second quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after acquiring an additional 524 shares in the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other Bath & Body Works news, CEO Gina Boswell acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were bought at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the transaction, the chief executive officer now owns 242,987 shares of the company’s stock, valued at approximately $7,202,134.68. This represents a 2.53 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.
Bath & Body Works Price Performance
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.03. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The company had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter last year, the business posted $0.48 earnings per share. The firm’s revenue was up 3.1% compared to the same quarter last year. On average, analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.
Bath & Body Works Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 22nd were given a $0.20 dividend. The ex-dividend date was Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.07%. Bath & Body Works’s dividend payout ratio (DPR) is presently 19.51%.
Wall Street Analysts Forecast Growth
Several research firms have recently issued reports on BBWI. Morgan Stanley reduced their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. TD Cowen increased their price objective on Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, December 12th. Telsey Advisory Group reissued an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. Citigroup reduced their price objective on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a report on Tuesday, August 20th. Finally, The Goldman Sachs Group reduced their price objective on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Bath & Body Works currently has an average rating of “Moderate Buy” and an average price target of $42.50.
View Our Latest Stock Report on BBWI
Bath & Body Works Company Profile
Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- NYSE Stocks Give Investors a Variety of Quality Options
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- What is the Euro STOXX 50 Index?
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Stock Average Calculator
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.